Molecular Analysis for Combination Therapy Choice (ComboMATCH) Protocol EAY191-A3, A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancers (NCT05554367)

Primary Objective

To screen and assign patients to ComboMATCH treatment trials.

Is This Study For You?

Let's Get Started!

Description

To screen and assign patients to ComboMATCH treatment trials.

Details
Age
Adult
Eligibility
Detailed eligibility criteria is available on ClinicalTrials.gov. These requirements will be discussed with your doctor and/or study representative. Visit ClinicalTrials.gov to learn more about this study.
Locations

Greeley Campus
Harmony Campus
Medical Center of the Rockies
Outpatient CTRC
Poudre Valley Hospital
University of Colorado Hospital

Principal Investigator
Photograph of Robert Lentz

Robert Lentz

Study ID

Protocol Number: 24-0233

More information available at ClinicalTrials.gov: NCT05554367

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers